undamentalytics Newsletter

Sellers Robert W.A.: insider trades

Officer at Edwards Lifesciences. No open-market purchases and 15 sales not made under a pre-set plan, reported from August 1, 2014 to February 12, 2024.

What happened after Sellers Robert W.A.’s sales?

After their sales, the shares moved +10.2% against the index over 12 months on average (a negative figure means selling was the right call); 27% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Sellers Robert W.A.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 15 +2.9% +3.2% 40% 10 0.22 0.83 No reliable evidence
Sales, 12 months after the report 15 +10.2% +13.5% 27% 10 0.56 0.59 No reliable evidence
Sales, 12 months after the trade 15 +10.1% +10.5% 27% 10 0.49 0.64 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Edwards Lifesciences EW SVP, Corporate Controller015August 1, 2014February 12, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 12, 2024February 12, 2024 EW Sale $1,062,270 −6.0%−36.7%−36.0%
April 28, 2023April 28, 2023 EW Sale $1,069,944 −16.6%−25.9%−26.2%
April 23, 2021April 23, 2021 EW Sale $1,171,920 +7.4%+20.8%+17.9%
August 27, 2020August 27, 2020 EW Sale $1,779,204 −3.0%+9.1%+7.9%
July 26, 2019July 25, 2019 EW Sale $3,684,962 +5.0%−1.2%+1.2%
April 26, 2019April 26, 2019 EW Sale $143,971 +21.0%+23.1%+25.0%
February 22, 2019February 22, 2019 EW Sale $87,520 −2.2%+17.5%+13.5%
February 21, 2019February 21, 2019 EW Sale $459,235 −3.0%+13.5%+10.5%
November 23, 2018November 20, 2018 EW Sale $1,203,631 +6.1%+41.0%+42.5%
February 6, 2018February 5, 2018 EW Sale $1,574,912 +3.2%+29.6%+29.3%
April 28, 2017April 27, 2017 EW Sale $1,419,120 +0.9%+7.5%+4.0%
August 1, 2016July 29, 2016 EW Sale $1,143,300 −15.3%−16.5%−15.4%
November 23, 2015November 23, 2015 EW Sale $754,224 +15.9%+0.6%−2.2%
November 13, 2014November 13, 2014 EW Sale $422,518 +4.4%+21.6%+21.9%
August 1, 2014July 31, 2014 EW Sale $809,510 +25.0%+49.8%+57.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Sellers Robert W.A. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.